What does CUSIP 379577208 represent in this 13F holders report?

CUSIP 379577208 is the security identifier for GMED - GLOBUS MEDICAL INC - Class A Stock used to aggregate holder disclosures.

How many institutions held GMED - GLOBUS MEDICAL INC - Class A Stock in Q2 2017?

240 institutional investors reported GMED - GLOBUS MEDICAL INC - Class A Stock for Q2 2017. Use the holders table for investor-level position and value details.

GLOBUS MEDICAL INC - Class A Stock (GMED)

CUSIP: 379577208

Q2 2017 13F Holders as of 30 Jun 2017

Type / Class: Equity / Class A Stock
Shares outstanding: 115,244,363
Total 13F shares: 63,912,936
Share change: -434,741
Total reported value: $2,113,531,840
Put/Call ratio: 0%
Price per share: $33.15
Number of holders: 240
Value change: -$6,742,413
Number of buys: 136
Number of sells: 106

Quarterly Holders Quick Answers

What is CUSIP 379577208?
CUSIP 379577208 identifies GMED - GLOBUS MEDICAL INC - Class A Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2017
Previous quarter: Q1 2017

Recent filing periods for CUSIP 379577208:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of GMED - GLOBUS MEDICAL INC - Class A Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BlackRock Finance, Inc.	13F	Company	6.4%	7,387,282	$218,812,000	—	31 Mar 2017	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	5.8%	6,733,189	$199,438,000	—	31 Mar 2017	13F
VANGUARD GROUP INC	13F	Company	4.9%	5,635,698	$166,929,000	—	31 Mar 2017	13F
Consonance Capital Management LP	13F	Company	2.5%	2,935,000	$86,935,000	—	31 Mar 2017	13F
Bank of New York Mellon Corp	13F	Company	2.3%	2,629,314	$77,878,000	—	31 Mar 2017	13F
STATE STREET CORP	13F	Company	1.9%	2,246,728	$66,545,000	—	31 Mar 2017	13F
JANUS HENDERSON INVESTORS US LLC	13F	Company	1.7%	1,981,838	$58,702,000	—	31 Mar 2017	13F
Van Berkom & Associates Inc.	13F	Company	1.7%	1,971,620	$58,399,000	—	31 Mar 2017	13F
ABERDEEN ASSET MANAGEMENT PLC/UK	13F	Company	1.6%	1,886,587	$55,880,000	—	31 Mar 2017	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	1.6%	1,831,360	$54,244,000	—	31 Mar 2017	13F
OAK RIDGE INVESTMENTS LLC	13F	Company	1.4%	1,654,676	$49,012,000	—	31 Mar 2017	13F
GW&K Investment Management, LLC	13F	Company	1.3%	1,487,753	$44,067,000	—	31 Mar 2017	13F
GLENMEDE TRUST CO NA	13F	Company	1.3%	1,486,012	$43,962,000	—	31 Mar 2017	13F
ROYAL BANK OF CANADA	13F	Company	1.1%	1,305,124	$38,659,000	—	31 Mar 2017	13F
NORTHERN TRUST CORP	13F	Company	1%	1,205,926	$35,720,000	—	31 Mar 2017	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0.96%	1,105,424	$32,743,000	—	31 Mar 2017	13F
NORGES BANK	13F	Company	0.82%	944,556	$27,978,000	—	31 Mar 2017	13F
RICE HALL JAMES & ASSOCIATES, LLC	13F	Company	0.72%	827,526	$24,511,000	—	31 Mar 2017	13F
NUANCE INVESTMENTS, LLC	13F	Company	0.71%	815,053	$24,142,000	—	31 Mar 2017	13F
PARADIGM CAPITAL MANAGEMENT INC/NY	13F	Company	0.69%	793,900	$23,516,000	—	31 Mar 2017	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.65%	750,463	$22,228,000	—	31 Mar 2017	13F
JANUS HENDERSON GROUP PLC	13F	Company	0.65%	745,273	$22,075,000	—	31 Mar 2017	13F
AXA S.A.	13F	Company	0.61%	706,324	$20,921,000	—	31 Mar 2017	13F
SENTINEL ASSET MANAGEMENT, INC.	13F	Company	0.57%	653,827	$19,366,000	—	31 Mar 2017	13F
ANCHOR CAPITAL ADVISORS LLC	13F	Company	0.51%	590,822	$17,500,000	—	31 Mar 2017	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.51%	582,190	$17,245,000	—	31 Mar 2017	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.5%	578,179	$17,125,000	—	31 Mar 2017	13F
FMR LLC	13F	Company	0.43%	500,000	$14,810,000	—	31 Mar 2017	13F
Boston Trust Walden Corp	13F	Company	0.43%	494,595	$14,650,000	—	31 Mar 2017	13F
Nationwide Fund Advisors	13F	Company	0.42%	482,864	$14,302,000	—	31 Mar 2017	13F
Nuveen Asset Management, LLC	13F	Company	0.41%	469,841	$13,917,000	—	31 Mar 2017	13F
SENZAR ASSET MANAGEMENT, LLC	13F	Company	0.39%	447,100	$13,243,000	—	31 Mar 2017	13F
CITADEL ADVISORS LLC	13F	Company	0.36%	412,809	$12,227,000	—	31 Mar 2017	13F
BLUE JAY CAPITAL MANAGEMENT, LLC	13F	Company	0.35%	400,000	$11,848,000	—	31 Mar 2017	13F
AHL Partners LLP	13F	Company	0.34%	397,308	$11,769,000	—	31 Mar 2017	13F
Point72 Asset Management, L.P.	13F	Company	0.34%	388,700	$11,513,000	—	31 Mar 2017	13F
SCHRODER INVESTMENT MANAGEMENT GROUP	13F	Company	0.3%	348,500	$10,242,000	—	31 Mar 2017	13F
SEGALL BRYANT & HAMILL, LLC	13F	Company	0.28%	327,652	$9,705,000	—	31 Mar 2017	13F
MORGAN STANLEY	13F	Company	0.28%	322,181	$9,543,000	—	31 Mar 2017	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.28%	320,677	$9,498,000	—	31 Mar 2017	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	0.27%	308,000	$9,123,000	—	31 Mar 2017	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.25%	292,401	$8,661,000	—	31 Mar 2017	13F
PURA VIDA INVESTMENTS, LLC	13F	Company	0.25%	285,646	$8,461,000	—	31 Mar 2017	13F
MARATHON ASSET MANAGEMENT LLP	13F	Company	0.23%	267,459	$7,922,000	—	31 Mar 2017	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.2%	233,963	$6,945,000	—	31 Mar 2017	13F
GABELLI FUNDS LLC	13F	Company	0.2%	231,000	$6,842,000	—	31 Mar 2017	13F
Fiera Capital Corp	13F	Company	0.2%	230,154	$6,817,000	—	31 Mar 2017	13F
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC	13F	Company	0.19%	221,011	$6,547,000	—	31 Mar 2017	13F
Marshall Wace North America L.P.	13F	Company	0.19%	215,414	$6,462,000	—	31 Mar 2017	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.18%	208,827	$6,185,000	—	31 Mar 2017	13F

Institutional Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) as of Q2 2017

As of 30 Jun 2017, GLOBUS MEDICAL INC - Class A Stock (GMED) was held by 240 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 63,912,936 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, Consonance Capital Management LP, JANUS HENDERSON GROUP PLC, Bank of New York Mellon Corp, STATE STREET CORP, Van Berkom & Associates Inc., ABERDEEN ASSET MANAGEMENT PLC/UK, and DIMENSIONAL FUND ADVISORS LP. This page lists 240 institutional shareholders reporting positions in this security for the Q2 2017 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2017 vs Q1 2017 Across Filers

Q1 2017 holders

240

Q2 2017 holders

240

Holder diff

Investor	Q1 2017 Shares	Q2 2017 Shares	Share Diff	Share Chg %	Q1 2017 Value $	Q2 2017 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.